Cancer incidence and mortality projections in the UK until 2035
- PMID: 27727232
- PMCID: PMC5117795
- DOI: 10.1038/bjc.2016.304
Cancer incidence and mortality projections in the UK until 2035
Abstract
Background: Cancer incidence and mortality projections are important for understanding the evolving landscape for cancer risk factors as well as anticipating future burden on the health service.
Methods: We used an age-period-cohort model with natural cubic splines to estimate cancer cases and deaths from 2015 to 2035 based on 1979-2014 UK data. This was converted to rates using ONS population projections. Modified data sets were generated for breast and prostate cancers.
Results: Cancer incidence rates are projected to decrease by 0.03% in males and increase by 0.11% in females yearly between 2015 and 2035; thyroid, liver, oral and kidney cancer are among the fastest accelerating cancers. 243 690 female and 270 261 male cancer cases are projected for 2035. Breast and prostate cancers are projected to be the most common cancers among females and males, respectively in 2035. Most cancers' mortality rate is decreasing; there are notable increases for liver, oral and anal cancer. For 2035, there are 95 961 female deaths projected and 116 585 male deaths projected.
Conclusions: These findings stress the need to continue efforts to address cancer risk factors. Furthermore, the increased burden of the number of cancer cases and deaths as a result of the growing and ageing population should be taken into consideration by healthcare planners.
Figures




Similar articles
-
Years of potential life lost caused by prostate cancer deaths in the United States-Projection from 2004 through 2050.Cancer Epidemiol. 2010 Aug;34(4):368-72. doi: 10.1016/j.canep.2010.04.015. Epub 2010 May 26. Cancer Epidemiol. 2010. PMID: 20510666
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
Projection of burden of cancer mortality for India, 2011-2026.Asian Pac J Cancer Prev. 2013;14(7):4387-92. Asian Pac J Cancer Prev. 2013. PMID: 23992008
-
Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017.Asia Pac J Clin Oncol. 2018 Feb;14(1):5-15. doi: 10.1111/ajco.12761. Epub 2017 Sep 20. Asia Pac J Clin Oncol. 2018. PMID: 28929586 Review.
-
Global patterns of cancer incidence and mortality rates and trends.Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907. doi: 10.1158/1055-9965.EPI-10-0437. Epub 2010 Jul 20. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20647400 Review.
Cited by
-
Prognostic risk factor analysis and nomogram construction for primary liver cancer in elderly patients based on SEER database.BMJ Open. 2022 Oct 26;12(10):e051946. doi: 10.1136/bmjopen-2021-051946. BMJ Open. 2022. PMID: 36288830 Free PMC article.
-
Interactive training workshop to improve prostate mpMRI knowledge: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.Insights Imaging. 2024 Jan 25;15(1):27. doi: 10.1186/s13244-023-01574-8. Insights Imaging. 2024. PMID: 38270689 Free PMC article.
-
Tackling Thyroid Cancer in Europe-The Challenges and Opportunities.Healthcare (Basel). 2022 Aug 25;10(9):1621. doi: 10.3390/healthcare10091621. Healthcare (Basel). 2022. PMID: 36141235 Free PMC article.
-
A Novel Approach to Modeling and Forecasting Cancer Incidence and Mortality Rates through Web Queries and Automated Forecasting Algorithms: Evidence from Romania.Biology (Basel). 2022 Jun 3;11(6):857. doi: 10.3390/biology11060857. Biology (Basel). 2022. PMID: 35741378 Free PMC article.
-
Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.JAMA Intern Med. 2018 Sep 1;178(9):1210-1222. doi: 10.1001/jamainternmed.2018.2820. JAMA Intern Med. 2018. PMID: 30083701 Free PMC article.
References
-
- Bray F, Møller B (2006) Predicting the future burden of cancer. Nat Rev Cancer 6: 63–74. - PubMed
-
- Duffy SW, Nagtegaal ID, Wallis M, Cafferty FH, Houssami N, Warwick J, Allgood PC, Kearins O, Tappenden N, O'Sullivan E, Lawrence G (2008) Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol 168: 98–104. - PubMed
-
- Ellis L, Woods LM, Estéve J, Eloranta S, Coleman MP, Rachet B (2014) Cancer incidence, survival and mortality: explaining the concepts. Int J Cancer 135(8): 1774–1782. - PubMed
-
- Eurostat (2013) Available at: http://ec.europa.eu/eurostat/en/web/products-manuals-and-guidelines/-/KS... accessed September 2015.
-
- Health and Social Care Information Centre Health Survey for England (2012) Available at: http://www.hscic.gov.uk/catalogue/PUB13218 (accessed April 2016).
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources